Ucyclyd Report issue

Contributed to NME For profit Phase 1
Founded: Scottsdale AZ United States (1988)
Status: Acquired by Medicis (1999) → now Bausch Health Companies (2012)

Organization Overview

First Clinical Trial
2005
NCT00977600
First Marketed Drug
1996
sodium phenylbutyrate (buphenyl)
First NDA Approval
1996
sodium phenylbutyrate (buphenyl)
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ucyclyd Pharma, Inc.